The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBowleven Regulatory News (BLVN)

Share Price Information for Bowleven (BLVN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
BLVN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

26 Sep 2023 07:00

RNS Number : 5955N
Bowleven plc
26 September 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

26 September 2023

 

Bowleven plc

('Bowleven' or 'the Group' or 'the Company')

 

Corporate Update

 

Bowleven (AIM: BLVN), the Africa focused oil and gas, exploration and production company with key interests in Cameroon, provides a corporate and operational update.

 

New Age Etinde stake sale to Perenco

 

Despite the elapse of time since the signing of the agreements for the sale by New Age (African Global Energy) Limited ("New Age") of its 37.5% stake in, and the operatorship of, the Etinde project (the "Transaction") to Perenco S.A. ("Perenco"), completion remains outstanding.

 

The Company understands that a number of conditions to the completion of the Transaction remain, principally including the approval of Société Nationale des Hydrocarbures ("SNH"), the national oil and gas company of Cameroon. The Company notes that SNH's approval, the next key milestone towards completion of the Transaction, has remained outstanding for a significant period and it remains uncertain when a decision will be made by SNH whether to approve the Transaction, if at all.

 

Whilst Bowleven is not a party to Transaction discussions, the Company understands that, although the formal long-stop date under the agreement between New Age and Perenco passed on the 30th June 2023, both parties continue to seek to progress with the Transaction. Nevertheless, given the passage of time and the geopolitical disruptions in neighbouring countries, Bowleven reminds stakeholders that there can be no guarantee either that the Transaction will complete, or as to the timing of completion.

 

 

Corporate and Financing

 

In its interim results statement on 30 March 2023, the Company highlighted a material uncertainty regarding the going concern status of the Group; noting that it had been considering its fundraising options and expects to seek to raise additional equity capital in 2023 to help to finance the Group's ongoing corporate activities and to assist with financing its share of future expenditure as the Etinde project progresses towards FID.

 

As at 23rd September 2023, the Group had unaudited cash of c. $1.25 million, having divested of any remaining financial investments during 2023. The Company noted on 30 March 2023 that it had significantly reduced the Group's cost base. The Board of the Company believes that its cash resources will currently only allow it to fund the Group through to the end of calendar Q1 2024, assuming that Bowleven's contribution towards costs at Etinde remains at current low levels throughout that period (which may or may not be the case depending on whether the Transaction completes).

 

As set out in the Company's announcement on 21 July 2023, planning for a fundraising during 2023 has continued and the Company continues to seek, consider and evaluate possible options to raise additional capital to fund the Group's operations. The Board had originally expected that the Transaction would have closed substantially earlier. The extended delay, with no established timeline to closing of the Transaction, has created uncertainty as regards potential additional risks associated with the Etinde project and the Company is currently considering a fundraising proposal from a shareholder which contemplates the shareholder providing equity capital at a very substantial discount to the current market price of Bowleven's ordinary shares, whilst allowing all current shareholders to participate at the same price. The fundraising is not yet at an advanced stage and therefore there can be no certainty that a fundraising will be concluded, nor as to the structure or terms of any such fundraising.

 

The Company will provide further updates as appropriate.

 

 

ENQUIRIES

For further information, please contact:

 

Bowleven plc

Eli Chahin, Chief Executive

00 44 203 327 0150

 

Camarco (Financial PR)

Owen Roberts

Hugo Liddy

 

00 44 203 757 4980

 

Shore Capital (NOMAD and Broker)

Robert Finlay

00 44 20 7408 4090

Daniel Bush

Angus Murphy

 

A copy of this announcement is available on the Bowleven website www.bowleven.com

 

Notes to Editors:

Bowleven plc is an African focused oil and gas group, based in London and traded on AIM. It is dedicated to realising material shareholder value from its Etinde asset in Cameroon, whilst maintaining capital discipline and employing a rigorously selective approach to other value-enhancing opportunities. Bowleven holds a strategic equity interest in the offshore, shallow water Etinde permit (operated by New Age) in Cameroon.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPPURABUPWGBA
Date   Source Headline
9th Apr 20243:43 pmRNSHolding(s) in Company
3rd Apr 202410:35 amRNSResults of Open Offer
2nd Apr 20241:43 pmRNSResult of General Meeting
27th Mar 20247:00 amRNSInterim Results
18th Mar 20247:54 amRNSHolding(s) in Company
15th Mar 20247:00 amRNSStandard form for notification of major holdings
14th Mar 20247:00 amRNSProposed Underwritten Open Offer to raise c$2m
12th Mar 20243:49 pmRNSHolding(s) in Company
25th Jan 202410:59 amRNSTermination of Transaction
6th Dec 20233:43 pmRNSRESULT OF ANNUAL GENERAL MEETING
15th Nov 20235:47 pmRNSPosting of Annual Report and Accounts 2023
10th Nov 20237:00 amRNSFull Year Results
9th Nov 20237:00 amRNSBlock Admission Six Monthly Return
26th Sep 20237:00 amRNSCorporate Update
21st Jul 20237:00 amRNSResponse to Share Price Movement
9th May 20237:00 amRNSBlock Admission Six Monthly Return
30th Mar 20237:00 amRNSInterim Results
25th Jan 202311:00 amRNSPrice Monitoring Extension
25th Jan 20239:05 amRNSSecond Price Monitoring Extn
25th Jan 20239:00 amRNSPrice Monitoring Extension
1st Dec 202211:48 amRNSRESULT OF ANNUAL GENERAL MEETING
9th Nov 20227:00 amRNSBlock Admission Six Monthly Return
7th Nov 20227:00 amRNSPosting of Annual Report and Accounts 2022
1st Nov 20224:41 pmRNSSecond Price Monitoring Extn
1st Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20227:30 amRNSFull Year Results
18th Aug 20224:41 pmRNSSecond Price Monitoring Extn
18th Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 202211:05 amRNSSecond Price Monitoring Extn
18th Aug 202211:00 amRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSChange of Partner and Operator at Etinde Licence
13th Jun 20222:05 pmRNSSecond Price Monitoring Extn
13th Jun 20222:00 pmRNSPrice Monitoring Extension
7th Jun 202211:00 amRNSPrice Monitoring Extension
7th Jun 20227:00 amRNSChange of Partner and Operator at Etinde Licence
23rd May 20222:05 pmRNSSecond Price Monitoring Extn
23rd May 20222:00 pmRNSPrice Monitoring Extension
9th May 20228:32 amRNSBlock Admission Six Monthly Review
30th Mar 20227:00 amRNSInterim Results
13th Dec 20212:06 pmRNSSecond Price Monitoring Extn
13th Dec 20212:01 pmRNSPrice Monitoring Extension
8th Dec 202111:53 amRNSRESULT OF ANNUAL GENERAL MEETING
15th Nov 20217:00 amRNSPosting of Annual Report and Accounts 2021
10th Nov 202111:05 amRNSSecond Price Monitoring Extn
10th Nov 202111:00 amRNSPrice Monitoring Extension
10th Nov 20217:00 amRNSFull Year Results
9th Nov 20218:55 amRNSBlock Admission Six Monthly Return
20th Aug 20214:41 pmRNSSecond Price Monitoring Extn
20th Aug 20214:36 pmRNSPrice Monitoring Extension
20th Aug 20212:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.